Abstract
Brachytherapy treatment planning systems (BTPS) are employing the American Association of Physicists in Medicine (AAPM) Task Group 43 (TG‐43)‐recommended dosimetric parameters of sources, which are measured in water. The majority of brachytherapy implant volumes are not homogeneous media. Particularly, an implant with multiple seeds significantly changes homogeneity of the implant volume. Heterogeneities, such as attenuation by adjacent seeds or interseed attenuation (ISA), are neglected to this day in all BTPS. The goal of this project is to determine a novel analytical method to evaluate the impact of the dose perturbations (P‐value) and/or interseed attenuation effect (ISA‐value). This method will be validated for low‐ and high‐energy brachytherapy seeds such as and using Monte Carlo (MC) simulation techniques. In this analytical model, determination of dose perturbation and interseed attenuation in a multisource brachytherapy implant is based on MC‐simulated 3D kernels of P‐values and ISA data for single active and single dummy configurations, arranged at different distances and orientations relative to each other. The accuracy of the final model in multisource implant configurations has been examined by a comparison of the calculated P‐values and ISA‐values with full Monte Carlo water simulations (FMCWS). This model enabled us to determine the total perturbation and ISA values for any multisource implant, and the results are in excellent agreement with the FMCWS data. The advantage of this model to FMCWS for daily clinical application is the speed of the calculations and ease of the implementation. The new perturbation and ISA formulism have shown a better accuracy for than due to Compton scattering and its independence of the atomic number of the chemical composition of the phantom materials. The maximum difference between the ISA model and FMCWS for all cases was less than 5%. This new model can provide inputs for brachytherapy planning software to consider the ISA effect in dose calculations based on TG‐43U1 algorithm. This approach is applicable for energy range of to sources.
PACS number: 87.53.Jw
Keywords: LDR brachytherapy, interseed effect, ISA, TG‐43U1, Monte Carlo
I. INTRODUCTION
Dose calculation algorithms provided by the American Association of Physicists in Medicine (AAPM) Task Group (TG‐43) (1) are used in nearly all commercially available brachytherapy treatment planning systems (BTPS). In 2004 these algorithms were updated to TG‐43U1 (2) and then with a supplement to TG‐43U1S1 3 , 4 in 2010. These protocols are based on the superposition of a single source dose distribution obtained in the center of a homogenous water phantom with enough volume for radiation scattering. TG‐43 reports ignore the impact of sufficient phantom size effect, (5) presence of various tissue types 6 , 7 which have different chemical compositions than water, 8 , 9 presence of applicators, (10) and presence of other brachytherapy seeds 11 , 12 within the implanted volume. Brachytherapy seeds are normally composed of radioactive beads or rods encapsulated with metal with additional high‐z pellets as radio‐opaque markers for their identifications during postimplant CT localization. These high‐z materials in multisource brachytherapy implants will attenuate radiation passing through them and will impair predicted dose distributions calculated through a BTPS that utilizes the dosimetric parameters measured in homogeneous water phantom. The dose attenuation or perturbation of one seed by other seeds, located in the path of its photons, before reaching interaction points in the tissue is termed as “interseed attenuation” (ISA). ISA was first defined by Meigooni et al. (12) as “the ratio of the dose to a point due to an implant as a whole over the sum of the individual doses due to all seeds in implant, for a multi‐seed implant configuration.” They concluded that the measurement mean values of the ISA for two‐plane implants of seed arrays of seeds in a solid water phantom was 6% and the maximum was 12%, and concluded that these shortcomings can lead to inaccuracy in BTPS. While AAPM TG‐64 (13) guidelines for permanent prostate implant brachytherapy reported the inaccuracies as negligible, several studies have shown that the ISA is the difference between the full Monte Carlo (FMC) and superposition Monte Carlo (SMC) for multiple seed configurations in water. 9 , 14 , 15 Mobit and Badragan (14) have shown that the ISA effect in a 27 uniform spacing seeds implant of is up to 10%. Carrier et al. (9) published that the FMC and SMC differences of for prostate's ranged from 5.8% to 12.8%. Chibani et al. (15) reported that the missing ISA effect overestimates by 2% and 5% for and prostate implant, respectively. The ISA effect is dependent on seed composition, (16) configuration, 12 , 17 seed density (9) (number of seeds per unit implant volume), orientation, (12) and seed‐to‐seed distances. 11 , 14 The active AAPM TG‐186 (8) has focused on investigating model‐based dose calculation (MBDC) algorithms beyond the shortcomings of TG‐43. MBDC algorithms, such as MC simulation techniques, are one approach to solving the ISA shortcoming. This approach requires voxel‐by‐voxel knowledge of seed density and composition.
This project is focused on a new approach based on an analytical model from precalculated dose perturbation kernels for a single active source by another source which is located at different distances and different orientations relative to the active source. These dose perturbation kernels are calculated using the MCNP5 MC simulation technique for different source models. The accuracy of this model has been examined for multisource implants with and brachytherapy sources. This model could be easily implemented in any BTPS.
II. MATERIALS AND METHODS
A. tG‐43u1 dose calculation
Dose calculation techniques in brachytherapy use the TG‐43 (1) or TG‐43U1 2 , 3 , 4 parameters based on measurement or MC simulation in a homogenous water phantom. The two‐dimensional (2D) dose rate in a polar coordinate system around a sealed brachytherapy source, using line source approximation, is given by:
(1) |
where Λ is the dose rate constant is the air‐kerma strength of the source is the geometry function where the subscript “L” indicates a line source, is the radial dose function, and F(r, θ) is the 2D anisotropy function, and is the reference point on the transverse bisector of the source at 1 cm from its center. As shown in TG‐43 and TG‐43U1, dose rate distributions of multisource implants are calculated by superposition of the dose distributions from the individual sources.
B. Brachytherapy seed models
B.1. Source of I‐125 (Model 6702)
Schematic dimensions and composition of the brachytherapy seed model 6702 by Amersham Health (Burlington, Ontario, Canada) are taken from TG‐43U1. The 6702 source consists of three resin spheres, each with a diameter of 0.600 mm, (resin density is and molecular composition is . (18) The spheres are coated with which is assumed to have negligible thickness in this study. The spheres are encapsulated in a titanium tube with 0.050 mm thick walls and an outer diameter of 0.800 mm. End welds are 0.500 mm thick and are modeled as hemispheres on top of solid cylinders that have a 0.400 mm radius and are 0.100 mm thick. (19) The overall length is 4.60 mm and the active length is 3.30 mm (calculated using the TG‐43, effective line source length with a seed spacing of 1.10 mm and sources). The average photon energy emitted by the 6702 seed is about 28.5 keV. (1) The dosimetric parameters of this source are available in TG‐43U1 report. Although this source model is utilized in this project, the concept of ISA analytical model introduced in this project is applicable to other source models.
B.2. Ir‐192 source (Flexisource Model)
Dimensions of the Flexisource source are taken from the study by Granero et al. (20) This source model consists of a 3.50 mm long active core (density 22.42 g/cm3) with a diameter of 0.60 mm. The active core is covered by a 0.85 mm diameter and 4.6 mm total length of AISI 304 stainless steel capsule (composition by weight: Fe 67.92%, Cr 19%, Ni 10%, Mn 2%, Si 1%, and C 0.08%, and density of ). The 304 stainless steel cable has been modeled as a cylinder of 5 mm length and 0.5 mm in diameter. The tip of the encapsulation is assumed to be a 0.108 mm thick conical section with a half angle of 23.6° and the radius of the face being 0.17 mm. The conical section is attached to a 0.49 mm long solid cylindrical section followed by a 3.6 mm long hollow section with an inner radius of 0.335 mm. Following the hollow section is a 0.40 mm long solid conical section with the half angle of the cone assumed to be 24°. Attached to the conical section is a 5 mm long section of AISI 304 stainless steel cable. The active length of this source is 3.50 mm. Although this source in reality is an HDR source model, it has been used here to simulate an LDR Ir‐192 source for multisource implant, not an HDR single source. The ISA model introduced here is applicable for any LDR Ir‐192 source model.
C. Monte carlo calculations
The MC code MCNP version 5 (MCNP5) is used in this study. (21) Sources ( or ) are simulated at the center of a water hemisphere of 40 cm radius (full scattering) made of cubes with scoring 3D voxels. Firstly, the radial dose and 2D anisotropy functions for and were calculated and validated with published data as recommended. Secondly, the ISA and P‐values problem were considered. The doses were estimated on a mesh with voxels of matrix for a plane. Each point is determined by its radial distance of “r” perpendicular to the long axis of the source and a Z‐distance parallel to the source longitudinal axis (along‐away table). Radial and Z‐distances were varied from to 10 cm. The *FMESH4 tally was used to score the dose distributions around the brachytherapy sources in a mesh with 3D voxels. The *FMESH4 tally card allows the user to define a mesh tally superimposed over the problem geometry, and provides energy flux in that can be converted to absorbed dose by applying suitable coefficients. The and gamma spectra used in this study have been obtained from the NuDat database (22) and TG‐43 protocol, (1) respectively. The β spectrum of the source has not been considered, since its contribution to the dose rate distribution for distances greater than 1 mm from the source is negligible due to the encapsulation and the plastic catheter through which the source is guided. 20 , 23 The density of the water used in the simulation was at 22°C as recommended in TG43U1. (2) All simulations were done with photon histories. The MC statistical uncertainties were less than 3% for all cases.
D. Analytical model for interseed attenuation (ISA) of a multisource implant
In the new analytical model, dose perturbation and ISA effect for each source in a low‐dose rate multisource implant is calculated by assuming that the source of interest is active and the other sources are inactive. The cumulative perturbations of the active source by the surrounding inactive sources were determined by multiplication of the perturbation effect from each inactive source, as shown below. The ISA effect formula used here is according to the definitions by Meigooni et al. (12) and Burns and Raeside. (11) In these definitions, the P‐values are defined as the ratio of the dose to a point due to an active seed, in the presence of the inactive source, to the dose without the presence of inactive source. In this project, the ISA‐value is the difference between unity and P‐value (i.e., 1‐P). In order to ease the introduction and verification of this model, three different sample implant configurations were utilized. P‐values for these samples cases were calculated using the model, as well the FMCWS of the multisource implant. For the three source arrangement (shown in Fig. 1), where the active source A has two inactive sources (B and C) located on its right, the impact of the inactive source C is calculated as:
(2) |
Similarly, the effect of the inactive source B is calculated as:
(3) |
From Eq. (3), one can extract the following equation as:
(4) |
(5) |
(6) |
Therefore, if we have the P‐value for the two individual inactive sources of B and C ( and ), we can calculate the cumulative P‐value for the combination of them by multiplying the individual values. Also, ISA‐value of the combination would be . A similar concept can be proven for the total P‐value or dose deposited from one active source and N adjacent inactive sources and can be written by:
(7) |
The ISA effect can be expressed by: ,
(8) |
With these calculation techniques, one can calculate the radial dose and anisotropy functions according to TG‐43U1 modified by the ISA effect for a single active source and adjacent dummy sources.
E. Model validation in three simple implants
The accuracy of the model (i.e., (7), (8)) has been examined in the energy range of to (28.5 keV to 380 keV) by comparison of the model base data with FMC‐simulated results for an active source being surrounded by four or more inactive sources with different configurations, as shown in Fig. 2. On this figure, the active source is shown in solid black color, while the inactive sources are shown in light green. The points of interest are shown in solid circular light blue symbols. The P‐values for any inactive seed position are determined with , where the subscript “i” is the number of the inactive sources. The following sections show the details of these tests:
A single active source ( or ) in center and four inactive seeds are placed at four different quadrants relative to the active source (Fig. 2(a)). This figure shows several points of interest shown with circular symbols, located at different locations relative to the active and inactive sources. The P‐values and ISA‐values from this configuration using (7), (8) are compared with the FMC simulations for the same source arrangements.
A single active source is located at the origin and four inactive sources are located on one side at different distances relative to the active source, as shown in Fig. 2(b). Several points of interest are chosen at various locations relative to the active and inactive sources.
A single source is located at the origin and seven inactive sources distributed at different locations in one quadrant of the plane relative to the active source, as shown in Fig. 2(c). Cases 2 and 3 are used frequently for interstitial permanent prostate brachytherapy implant where the seeds are inserted parallel to the axis of needle insertion.
III. RESULTS & DISCUSSION
A. Monte carlo simulation validations
A.1. Radial dose and 2D anisotropy function
The accuracy of MC simulation in this project was validated by simulating the radial dose function, mcg(r), of (model 6702) and (model Flexisource) sources and comparing results with published data. 2 , 18 , 19 , 20 Figures 3(a) and (b) show comparison of the mcg(r) simulated for and to the published data for radial distances ranging from 0.5 to 10 cm for and 0.25 to 20 cm for . The maximum differences between mcg(r) calculated in this project and reference data for and were found to be 1.4% and 1.8%, respectively. The relative MC statistical uncertainties on mcg(r) for and were less than 2.5% for all distances. Validation of MC simulation was also performed for the 2D anisotropy function, F(r, θ). A comparison between the present work and the published data by Weaver (24) for (model 6702) and published data by Granero et al. (20) for (Flexisource) sources are presented in Figs. 4(a) and 4(b), respectively. These results, for the radial distances of 1 and 5 cm, indicate excellent agreement (less than 2% discrepancy) with the published data by Weaver for all the angles except for small angles (less than 10°) where differences of up to 8% have been observed (TG43U1 for model 6702 is reported typically at 10%). Similarly, comparisons of data with the published data by Granero and colleagues are showing excellent agreement (within ) for radial distances of 1 and 7 cm and at polar angles of with 10° increments. The MC statistical uncertainties on F(r, θ) for the two seed models were less than 2.5%.
B. Interseed attenuation (ISA) models
B.1. Perturbation values for two sources (one single active and inactive seed)
According to Eq. (7), if the P‐values are available for binary combinations of one active and one inactive source, one can calculate the P‐value for any multisource implant.
Figures 5(a) and (b), present the typical P‐value for and sources, respectively, assuming that the active source is located at the origin and the inactive sources are located in all quadrants of the coordinate system. These results are for points of interest located along a transverse line that is 2 cm away from the transverse bisector of the active source (i.e., ). These results show that, if the inactive sources are located at or , the corresponding P‐values are unity (i.e., ) and hence . Moreover, it has been found that there is no significant impact of the inactive sources on the dose distribution of the active source in the second, third, and fourth quadrants. In other words, the presence or absence of the dummy sources in the second, third, or fourth plan quarter of the implant have no effect on the P‐values of the first plan quarter of implant. The P‐values for dummy positions for are also unity, which corresponded to dummy positions from (0, 1, 3) to (0, 1, 8) (Fig.5)). With this style, the ISA‐values are zero for any seed (active or inactive) positions after line (i.e., dummy position (0, 4, 5) or (0, 8, 2.25)) and/or ISA and P‐values ≠ 0 for dummy positions before line . This approach is applicable for the energy range of to seeds. For , Compton scattering is important and caused the photon scattering contribution to be higher than the photoelectric absorptions for . The P‐value accuracy, (3.5%), is better for than for , especially at greater distances.
B.2. Full Monte Carlo water simulations (FMCWS)
To check the accuracy of the model ((7), (8)) in multiple seed implants, three FMCWS configurations (Fig. 2) were considered. 1, 2, 3 show the perturbation formulism and FMCWS data, and these are also graphically shown with varying geometry in Fig. 2. The and average P‐values are shown here for symmetric FMCWS for case #1 (Fig. 2(a) and Table 1) at calculation points of are 0.8085 and 0.8675, respectively. For other calculation points in Table 1, the P‐values are approximately unity. One example is the calculation point of (0, 1, 1) for , which yields values of and . This confirms that the P‐values for dummies that are placed in second, third, and fourth quarters of the implant plan (, and ) are unity. As a rule of thumb, if a straight line is drawn from the active source to any calculation point and intersects inactive sources, those inactive sources have an effect on the perturbations, and the P‐values corresponding to other dummy sources are unity (Fig. 2(a)). On the other hand, any inactive sources which intersect the radiation path from the active source to any calculation point produce P‐values (ISA‐values) of less than one have an effect on the total perturbation (ISA). For , the statistical accuracy is better than due to higher photon scattering. In case#1, Table 1, the maximum differences between the P‐values under FMCWS () and the perturbation model () for and are less than 0.2% and 0.6%, respectively. 2, 3 present the P‐value calculation points equivalent to cases 2 and 3 in Figs. 2(b) and (c). For cases 2 and 3, inactive sources are parallel to each other (1 cm source‐to‐source center) and along the same longitudinal axis (0.5 cm source‐to‐source center). For cases 2 and 3, if the radiation path is intersected by any inactive sources, those inactive seeds have an effect on the P‐values and, thus, the P‐values for residual dummies are unity. For case 2 at a calculation point of (0, 5, 0), all four inactive seeds intersect the radiation path. The , and for are 0.866, 0.910, 0.935, 0.946, and 0.697, respectively, while these corresponding values for are 0.890, 0.898, 0.933, 0.939, and 0.700, respectively. For a calculation point of (0, 2.5, 0), two inactive seeds intersect the radiation path. The , and are 0.888, 0.941, 1, 1, and 0.836, respectively, while these values for are 0.855, 0.913, 1, 0.999, and 0.780, respectively. In Table 3 (case #3), the calculation points of (0, 4, 0), (0, 4, 0.25), (0, 4, 1), (0, 4, 1.5), and (0, 4, 2.25) are compared with different Z‐ axis values. According to case #3, for and at (0, 4, 0) and (0, 4, 0.25), and at (0, 4, 1), and at (0, 4, 1.5), and at (0, 4, 2.25), calculation points intersect the radiation path from the active source. In case #2, Table 2, the maximum differences between and for and are less than 3.7% and 4.7%, respectively, while these values in case #3 are less than 1.2% and 4.9% for and , respectively.
Table 1.
CASE #1 | Ir‐192 | I‐125 | ||||||
---|---|---|---|---|---|---|---|---|
Calculation Points |
|
|
|
|
||||
(0, 2, 0) |
|
1 |
|
0.995 | ||||
(0, 1, 0) |
|
1 |
|
0.997 | ||||
(0, 1, 1) |
|
0.867 |
|
0.809 | ||||
|
|
0.868 |
|
0.809 | ||||
(0, 0.5, 0) |
|
1 |
|
0.999 | ||||
|
|
1 |
|
0.998 | ||||
|
|
1 |
|
0.999 | ||||
|
|
0.999 |
|
0.997 | ||||
(0, 0, 0.5) |
|
1 |
|
0.999 | ||||
|
|
1 |
|
0.998 | ||||
(0, 1, 1) |
|
0.867 |
|
0.808 | ||||
|
|
0.868 |
|
0.808 |
Table 2.
CASE #2 | Ir‐192 | I‐125 | ||||||
---|---|---|---|---|---|---|---|---|
Calculation Points |
|
|
|
|
||||
(0, 5, 0) |
|
0.734 |
|
0.747 | ||||
(0, 4, 0.75) |
|
0.932 |
|
0.887 | ||||
|
|
0.933 |
|
0.886 | ||||
(0, 3, 3) |
|
1 |
|
0.998 | ||||
(0, 2.5, 0) |
|
0.845 |
|
0.789 | ||||
(0, 2.5, 1) |
|
1 |
|
0.994 | ||||
|
|
1 |
|
0.996 | ||||
(0, 1.75, 0) |
|
0.913 |
|
0.870 | ||||
(0, 1.5, 0.5) |
|
0.999 |
|
0.992 | ||||
(0, 1.25, 0.5) |
|
1 |
|
0.996 | ||||
(0, 1, 0.5) |
|
1 |
|
0.999 | ||||
(0, 0.75, 0.5) |
|
1 |
|
0.999 |
Table 3.
CASE #3 | Ir‐192 | I‐125 | ||||||
---|---|---|---|---|---|---|---|---|
Calculation Points |
|
|
|
|
||||
(0, 0, 1) |
|
0.803 |
|
0.639 | ||||
(0, 1, 2) |
|
0.997 |
|
0.980 | ||||
(0, 1.25, 1.75) |
|
0.923 |
|
0.854 | ||||
(0, 1.25, 1.25) |
|
0.918 |
|
0.867 | ||||
|
|
0.985 |
|
0.999 | ||||
(0, 3, 0) |
|
0.827 |
|
0.834 | ||||
(0, 4, 0) |
|
0.808 |
|
0.817 | ||||
(0, 4, 0.25) |
|
0.815 |
|
0.790 | ||||
(0, 4, 1) |
|
0.960 |
|
0.829 | ||||
(0, 4, 1.5) |
|
0.825 |
|
0.808 | ||||
(0, 4, 2.25) |
|
0.854 |
|
0.850 |
Approximately for all cases, the ISA‐values (P‐values) for are lower (higher) than for . This is due to having a higher energy and dominant Compton photon scattering interaction, while in the energy range (28.5 keV) of , photoelectric absorption is dominant. We select a limit such that, if the perturbation is less than 4%, we can neglect the ISA effect. If the differences between and are less than 4%, their P‐ or ISA‐values are considered equal. Figures 6(a) to 6(c) show the typical data accuracy of ISA‐ and P‐values model ((7), (8)) in comparison to FMCWS for all cases. The corresponding values for are shown in Figs. 7(a) to 7(c). For case #1, the ISA‐ and P‐values are symmetric, and from to 10 cm. The data are shown for , and 3 cm. The ISA‐ and P‐values at are zero and unity, respectively. This is due to the inactive seed positions not being in the radiation path. For and 3 cm, radiation paths are intersected by inactive seeds, and one can observe the perturbation effect. The maximum P‐values in case #1 for at and 3 cm are 77.5% and 78.3%, respectively, with ISA‐values of 22.5% and 21.7%. The corresponding values for are 85% and 80% (P‐values) and 15% and 20% (ISA‐values), respectively. In comparison to 6, 7, one can observe that the ISA‐values for are higher than for . In this case, the differences between FMCWS and perturbation formulism (model) are less than 0.5% and 0.8% for and , respectively.
Data for and (case #2) for , and 3 cm are shown in 6, 7, respectively. The maximum P‐values for at , and 3 cm are 68%, 85%, and 94%, respectively, with ISA‐values of 32%, 15%, and 6%, respectively. The corresponding values for are 72%, 89%, and 100% (P‐values) and 28%, 11%, and 0% (ISA‐values), respectively. For at and ( and ISA2) are 90% and 80% (10% and 20%), while and ( and ISA4) are 75% and 70% (25% and 30%), respectively. The corresponding values of , (or ) are 95%, 87.5%, 80%, 75% (or 5%, 12.5%, 20%, 25%), respectively. In this case, the differences between FMCWS and the perturbation model are less than 3.5% and 5% for and , respectively.
Data for and (case #3) at , and 3 cm, are shown in 6, 7. One can observe a maximum peak at for and 3 cm. This is due to one inactive seed being placed along the longitudinal active source axis at (0, 0, 0.5). The radiation path on line is not intersected by the inactive seed, so there is no peak at . The maximum P‐values (or ISA‐values) for at , and 3 cm are 80%, 67%, and 64% (or 20%, 33%, and 36%), respectively. The corresponding values for are 77%, 60%, and 80% (or 23%, 40%, and 20%), respectively. In case #3, the difference between FMCWS and perturbation model are less than 3% and 5% for and , respectively. For all cases, the perturbation and ISA model ((7), (8)) are applicable from to 10 cm in along and away distances and at energies of to .
IV. CONCLUSIONS
In this work, for first time, a new model for ISA correction based on TG‐43U1 and MC is used in dose calculation to improve the dose calculation accuracy. We provide a novel algorithm for determining the ISA model based on a group of binary combinations of one active and one inactive source using 3D MC calculations. This formulism is applicable for energies of to brachytherapy sources with good precision. The maximum difference between FMCWS and perturbation model for all cases are less than 3.5% and 5% for and , respectively.
As a first step, MCNP5 simulations were performed to determine the dose distribution from a single active source ( or ) placed at the center of the full scattering spherical water phantom. The phantom is made of 3D voxels in along (z‐axis) and away (r‐axis) format to score deposited dose. The along and away distances are from to 10 cm.
In the second step, dose perturbation has been evaluated for one single active source with an inactive source ( or ), located at different location and orientation relative to the active source. The maximum separation between the active and inactive sources in this study was chosen to be 6 cm to replicate the common clinical practices. The P‐values and ISA‐values are calculated in along‐away format.
In the third step, the accuracy of the model ((7), (8)) has been examined in the energy range of to (28.5 keV to 380 keV) by comparison of the model base data with FMC simulated results for an active source being surrounded by inactive sources with different configurations, as shown in Fig. 2.
Based on this approach, one could expedite the processes of dose perturbation corrections with the minimal increase in planning time as compared to the FMCWS. With this and by using step 2 above, once trained, the network generalizes to produce ISA correction response. Then for any unknown combinations of an active and inactive source for which it has not been trained, the ISA correction data will be imported to the BTPS. More detailed work using these MC dose kernel databases is currently in progress to consider the real complex multisource implant configurations and to develop software to account for the ISA missing in TG‐43‐BTPS based on Artificial Neural Network (ANN) algorithm. (25) It should be noted that the geometries of the active and inactive sources were assumed to be parallel to each other. (7) Variations of the relative angles between the active and inactive sources are outside of the scope of this project and could be investigated in the future.
ACKNOWLEDGMENTS
The authors are very thankful to Drs. Shahid Awan, Hualin Zhang, and Courtney Knaup, and also Mr. Keith Sowards, for their valuable comments, sound editing analysis, and suggestions during the preparation of this manuscript.
REFERENCES
- 1. Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS. Dosimetry of interstitial b‐rachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No.43. Med Phys. 1995;22(2):209–34. [DOI] [PubMed] [Google Scholar]
- 2. Rivard MJ, Coursey BM, DeWerd LA, et al. Update of AAPM Task Group No. 43 Report: a revised AAPM protocol for brachytherapy dose calculations. Med Phys. 2004;31(3):633–74. [DOI] [PubMed] [Google Scholar]
- 3. Rivard MJ, Butler WM, DeWerd LA, et al. Supplement to the 2004 update of the AAPM Task Group No. 43 Report. Med Phys. 2007;34(6):2187–205. [DOI] [PubMed] [Google Scholar]
- 4. Rivard MJ, Butler WM, DeWerd LA, Ibbott GS, Meigooni AS, Melhus CS, Mitch MG, Nath R. Erratum: “Supplement to the 2004 update of the AAPM Task Group No. 43 Report”. Med Phys. 2010;37(5):2396. [DOI] [PubMed] [Google Scholar]
- 5. Perez‐Calatayud J, Granero D, Ballester F. Phantom size in brachytherapy source dosimetric studies. Med Phys. 2004;31(7):2075–81. [DOI] [PubMed] [Google Scholar]
- 6. Kirov AS, Williamson JF, Meiggoni AS, Zhu Y. Measurement and calculation of heterogeneity correction factors for an Ir‐192 high dose‐rate brachytherapy source behind tungsten alloy and steel shields. Med Phys. 1996;23(6):911–19. [DOI] [PubMed] [Google Scholar]
- 7. Meigooni AS and Nath R. Tissue inhomogeneity correction for brachytherapy sources in a homogeneous phantom with cylindrical symmetry. Med Phys. 1992;19(2):401–07. [DOI] [PubMed] [Google Scholar]
- 8. Beaulieu L, Carlsson Tedgren A, Carrier JF, et al. Report of the Task Group 186 on model‐based dose calculation methods in brachytherapy beyond the TG‐43 formalism: current status and recommendations for clinical implementation. Med Phys. 2012;39(10):6208–36. [DOI] [PubMed] [Google Scholar]
- 9. Carrier JF, Beaulieu L, Therriault‐Proulx F, Roy R. Impact of interseed attenuation and tissue composition for permanent prostate implants. Med Phys. 2006;33(3):595–604. [DOI] [PubMed] [Google Scholar]
- 10. Lymperopoulou G, Pantelis E, Papagiannis P, et al. A Monte Carlo dosimetry study of vaginal 192Ir brachytherapy applications with a shield cylindrical applicator set. Med Phys. 2004;31(11):3080–86. [DOI] [PubMed] [Google Scholar]
- 11. Burns GS, Raeside DE. The accuracy of single‐seed dose superposition for I‐125 implants. Med Phys. 1989;16(4):627–31. [DOI] [PubMed] [Google Scholar]
- 12. Meigooni AS, Meli JA, Nath R. Interseed effects on dose for 125I brachytherapy implants. Med Phys. 1992;19(2):385–90. [DOI] [PubMed] [Google Scholar]
- 13. Yu Y, Anderson LL, Li Z, et al. Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64. Med Phys. 1999;26(10):2054–76. [DOI] [PubMed] [Google Scholar]
- 14. Mobit P, Badragan I. Dose perturbation effects in prostate seed implant brachytherapy with I‐125. Phys Med Biol. 2004;49(14):3171–78. [DOI] [PubMed] [Google Scholar]
- 15. Chibani O, Williamson JF, Todor D. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants. Med Phys. 2005;32(8):2557–66. [DOI] [PubMed] [Google Scholar]
- 16. Afsharpour H, D'Amours M, Cote B, Carrier JF, Verhaegen F, Beaulieu L. A Monte Carlo study on the effect of seed design on the interseed attenation in permanent prostate implants. Med Phys. 2008;35(8):3671–81. [DOI] [PubMed] [Google Scholar]
- 17. Zhang H, Baker C, McKinsey R, Meigooni AS. Dose verification with Monte Carlo technique for prostate brachytherapy implants with 125I sources. Med Dosim. 2005;30(2):85–91. [DOI] [PubMed] [Google Scholar]
- 18. Mainegra E, Capote R, Lopez E. Dose rate constants for 125I, 103Pd, 192Ir and 196Yb brachytherapy sources: an EGS4 Monte Carlo Study. Phys Med Biol. 1998;43(6):1557–66. [DOI] [PubMed] [Google Scholar]
- 19. Hedtjarn H, Carlsson GA, Williamson JF. Monte Carlo‐aided dosimetry of the Symmetra model I25.S06 I125, interstitial brachytherapy seed. Med Phys. 2000;27(5):1076–85. [DOI] [PubMed] [Google Scholar]
- 20. Granero D, Perez‐Calatayud J, Casal E, Ballester F, Venselaar J. A dosimetric study on the Ir‐192 high dose rate flexisource. Med Phys. 2006;33(12):4578–82. [DOI] [PubMed] [Google Scholar]
- 21. MCNP‐5 Monte Carlo Team . MCNP – a general Monte Carlo N‐Particle transport code, version 5. Los Alamos, NM: Los Alamos National Laboratory; 2003. [Google Scholar]
- 22. National Nuclear Data Center . Nuclear data from NuDat (a web‐based database maintained by the National Nuclear Data Center). Upton, NY: Brookhaven National Laboratory; Retrived May 11, 2012. http://www.nndc.bnl.gov/nudat2/ [Google Scholar]
- 23. Baltas D, Karaiskos P, Papagiannis P, Sakelliou L, Loeffler E, Zamboglou N. Beta versus gamma dosimetry close to Ir‐192 brachytherapy sources. Med Phys. 2001;28(9):1875–82. [DOI] [PubMed] [Google Scholar]
- 24. Weaver K. Anisotropy functions for and sources. Med Phys. 1998;25(12):2271–78. [DOI] [PubMed] [Google Scholar]
- 25. Haykin S. Neural networks: a comprehensive foundation, 2nd edition. Upper Saddle River, NJ: Prentice Hall Press; 1999. [Google Scholar]